PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Oct-2025 Revvity to Hold Earnings Call on Monday, October 27, 2025 Businesswire
06-Oct-2025 Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy Businesswire
06-Oct-2025 Stoke Therapeutics Appoints Ian F. Smith as Chief Executive Officer Businesswire
06-Oct-2025 Protein Engineering for Pharmaceutical Biotechnology Training Course | Enhance Your Knowledge in Protein Engineering to Understand How to Advance Therapeutic Developments (Jan 21st - Jan 22nd, 2026) - ResearchAndMarkets.com Businesswire
06-Oct-2025 Aqemia to Participate in Jefferies European Disruptive Tech Conference Businesswire
06-Oct-2025 CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting Businesswire
06-Oct-2025 KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer Businesswire
06-Oct-2025 Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases Businesswire
06-Oct-2025 Within3 Names Ian McKinnon, Ph.D., as Managing Director, Global Head of Consulting Businesswire
06-Oct-2025 Owlstone Medical Wins up to $49.1 Million Award from ARPA-H to Develop At-home Multi-Cancer-Early Detection Tests Businesswire
06-Oct-2025 Lilly and Leading Alzheimer’s Disease Experts Call for Urgent Action to Close Diagnostic Gaps at Alzheimer Europe Conference Eli Lilly and Company
06-Oct-2025 President of The Physiological Society congratulates 2025 Nobel Prize winners The Physiological Society
06-Oct-2025 Adva Biotechnology and Autolomous Launch the Digital PIONEER Program to Enable Decentralized, Scalable Cell Therapy Manufacturing — GenCART Inc. Joins as First Clinical Participant Adva Biotechnology Ltd
06-Oct-2025 Celltrion presents positive real-world data on switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions Celltrion inc
06-Oct-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-Oct-2025 Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study Businesswire
06-Oct-2025 GenesisCare UK appoints Dr Peter Dickinson to lead its Elekta Unity MR Linac programme Genesis Care UK
06-Oct-2025 Revolutionary blood test for ME / Chronic Fatigue unveiled University of East Anglia and Oxford Biodynamics
06-Oct-2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Onco3R Therapeutics
06-Oct-2025 Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions Businesswire